×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
Clinical Policy: Regorafenib (Stivarga)CRC, GIST, HCC 160 mg PO QD for the first 21 days of each 28-day cycle 160 mg/day VI. Product Availability Tablet: 40 mg . VII. References 1.
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form